We used lentiviral infection followed by clonal selection with plasmids for RNAi knockdown of Hsd17b7 to create cell lines with reduced levels of Hsd17b7 (approx. 80% reduced, data not shown) and then treated the lines with recombinant SHH, as done with the MEFs. The gene discussed is SHH; the disease is infection.